Clinical Trial Update: A Clinical Trial of Regorafenib in Patients With Pretreated Advanced Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating regorafenib in patients with pretreatment advanced melanoma (stages III and IV).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Regorafenib (regorafenib)

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Melanoma Stage III, Melanoma Stage IV | Phase 2 | Status: UNKNOWN